KROS

Keros Therapeutics Inc

NASDAQ · Biotechnology

$17.57

+0.33 (+1.91%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Buy

16 analysts

Buy 11 69%

Hold 5 31%

Sell 0 0%

Price Target

Analyst Price Target +12.1% upside

Low Target $13.49

Average Target $19.70

High Target $20.36

Current Price $17.57

Current
$17.57

Target
$19.70

$13.49 $19.70 avg $20.36